Conditional ablation of dendritic cells in transgenic mice

Area of Science:

• Immunology
• Cell Biology
• Genetics

Background:

• Dendritic cells (DCs) are critical for initiating adaptive immune responses and T cell development.
• Understanding the precise physiological roles of DCs requires specific tools to manipulate their numbers in vivo.
• Previous methods lacked specificity or efficiency in targeting DCs for depletion.

Purpose of the Study:

• To develop a conditional transgenic mouse model for targeted ablation of dendritic cells.
• To investigate the physiological impact of DC deficiency on the immune system, particularly thymocyte differentiation.
• To establish a tool for studying DC dysfunction in pathological contexts.

Main Methods:

• Generation of transgenic mice expressing herpes simplex virus type 1 thymidine kinase (HSV1-TK) under the control of HIV regulatory sequences for DC-specific expression.
• Conditional ablation of DCs using ganciclovir (GCV), a nucleoside analog that is converted to a toxic molecule by HSV1-TK.
• Analysis of DC populations in spleen and thymus following GCV treatment.
• Assessment of thymocyte populations (CD4+CD8+) and thymic structure.

Main Results:

• Transgenic mice exhibited HSV1-TK expression in mature DCs and DC precursors.
• GCV treatment specifically and efficiently depleted ~90% of splenic DCs within a week, indicating a high turnover rate.
• DC depletion led to significant thymic atrophy and a marked decrease in CD4+CD8+ thymocytes.
• The model demonstrated a clear correlation between DC numbers and thymocyte development.

Conclusions:

• The developed transgenic mouse model allows for effective, conditional depletion of DCs.
• Dendritic cells play an indispensable role in maintaining thymic architecture and supporting thymocyte differentiation.
• This model provides a valuable tool for dissecting DC functions in immunity and disease.